Berlin - Delayed Quote EUR

SynBiotic SE (SBX.BE)

Compare
6.00 +0.52 (+9.49%)
As of 6:47 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
3,861.36
3,861.36
8,165.63
8,648.55
5,472.18
--
Cost of Revenue
2,354.94
2,354.94
4,593.49
3,863.18
1,733.25
--
Gross Profit
1,506.42
1,506.42
3,572.13
4,785.37
3,738.93
--
Operating Expense
12,718.00
12,718.00
28,978.55
16,636.33
4,459.64
--
Operating Income
-11,211.58
-11,211.58
-25,406.41
-11,850.96
-720.71
--
Net Non Operating Interest Income Expense
-113.49
-113.49
-37.11
86.94
-2.64
--
Pretax Income
-11,871.18
-11,871.18
-26,186.44
-13,359.32
-858.80
--
Tax Provision
-134.91
-134.91
-188.81
-289.71
21.59
--
Net Income Common Stockholders
-10,630.60
-10,630.60
-24,362.17
-12,724.61
-880.39
--
Diluted NI Available to Com Stockholders
-10,630.60
-10,630.60
-24,362.17
-12,724.61
-880.39
--
Basic EPS
-2.24
--
-5.97
-4.09
-0.55
-0.05
Diluted EPS
-2.24
--
-5.97
-4.09
-0.55
-0.05
Basic Average Shares
4,749.32
--
4,081.78
3,112.51
1,584.88
254.77
Diluted Average Shares
4,749.32
--
4,081.78
3,112.51
1,584.88
254.77
Total Operating Income as Reported
--
--
--
--
--
-13.43
Total Expenses
15,072.94
15,072.94
33,572.04
20,499.51
6,192.89
--
Net Income from Continuing & Discontinued Operation
-10,630.60
-10,630.60
-24,362.17
-12,724.61
-880.39
--
Normalized Income
-9,889.61
-9,889.61
-23,342.16
-12,608.90
-801.14
--
Interest Income
81.75
81.75
151.79
133.58
20.23
--
Interest Expense
195.24
195.24
188.90
46.64
22.87
--
Net Interest Income
-113.49
-113.49
-37.11
86.94
-2.64
--
EBIT
-11,675.95
-11,675.95
-25,997.54
-13,312.68
-835.93
--
EBITDA
-7,122.60
-7,122.60
-7,485.66
-4,997.51
-716.12
--
Reconciled Cost of Revenue
2,354.94
2,354.94
4,593.49
3,863.18
1,733.25
--
Reconciled Depreciation
4,553.35
4,553.35
18,511.89
8,315.17
119.80
--
Net Income from Continuing Operation Net Minority Interest
-10,630.60
-10,630.60
-24,362.17
-12,724.61
-880.39
--
Total Unusual Items Excluding Goodwill
-749.51
-749.51
-1,027.42
-118.28
-113.21
--
Total Unusual Items
-749.51
-749.51
-1,027.42
-118.28
-113.21
--
Normalized EBITDA
-6,373.09
-6,373.09
-6,458.24
-4,879.23
-602.91
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-8.52
-8.52
-7.41
-2.56
-33.96
--
12/31/2019 - 1/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade